Staff Profile

Edit

Career Summary

Qualifications

  • Bachelor of Medicine, Bachelor of Surgery, University of Glasgow - Scotland

Research

Research keywords

  • Pharmaco-economics
  • Pharmaco-epidemiology

Research expertise

Evidence based medicine, adverse drug reactions pharmacovigilance, pharmaco-epidemiology and pharmaco-economics

Fields of Research

CodeDescriptionPercentage
111700Public Health And Health Services40
110300Clinical Sciences35
160508Health Policy25

Memberships

Body relevant to professional practice.

  • Australasian Society of Clinical and Experimental Pharamcologists
  • International Society of Pharmacoepidemiology
  • Director - World Health Organisation Collaborating Centre for training in Pharmo-economics and Rational Pharmacotherapy

Other

  • Member, panel of referees for project grants - National Health and Medical Research Council, Medical Research Council of New Zealand, Canadian Institutes of Health Research, Medical Research Council (UK)
  • Member - South African National Medicines Pricing Committee

Appointments

Chair
Medical Staff Council, Newcastle Mater Hospital (Australia)
01/01/2007

Awards

Joint Winner

2005Eureka Skeptics Prize for Critical Thinking
Australian Museum (Australia)
2001Thomas Chalmers Memorial Award
Ninth Cochrane Colloquium, 2001 (France)

Invitations

Pharmaco-economics
World Health Organisation, Australia (Consultant)
2007

Administrative

Administrative expertise

I have been discipline head since 1997 and have also served as Head of School (Population Health Sciences) and deputy head of school (Medicine and Population Health) at different times. I am Director of the Newcastle Institute of Public Health and Director of the WHO Collaborating Centre for Training in Pharmaco-economics and Rational Pharmacotherapy at the University of Newcastle. I am chair of medical staff council of the Newcastle Mater Hospital and have served on multiple committees, including ethics committees of the University and health service. I have been a member of several national committees concerned with drug regulation and for 8 years chaired the economics subcommittee of the Commonwealth governments Pharmaceutical Benefits Advisory Committee

Teaching

Teaching keywords

  • Clinical Pharmacology
  • General Medicine
  • Pharmaco-economics
  • Pharmaco-epidemiology

Teaching expertise

Clinical medicine, clinical pharmacology, rational drug use, pharmaco-epidemiology and pharmaco-economics

Edit

Highlighted Publications

For publications that are currently unpublished or in-press, details are shown in italics.

YearCitationAltmetricsLink
2006McGettigan PG, Henry DA, 'Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase', JAMA - Journal of the American Medical Association, 296 1633-1644 (2006) [C1]
2002Moynihan R, Heath I, Henry DA, 'Selling sickness: The pharmaceutical industry and disease mongering', British Medical Journal, 324 886-891 (2002) [C1]
2002Carson J, Hill SR, Carless PA, Hebert P, Henry DA, 'Transfusion Triggers: a systematic review of the literature', Transfusion Medicine Reviews, 16(3) 187-199 (2002) [C1]
2000Page J, Henry DA, 'Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients', Archives of Internal Medicine, 160(6) 777-784 (2000) [C1]

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Chapter (6 outputs)

YearCitationAltmetricsLink
2005Henry DA, McGettigan PG, Anne T, Sean H, 'Basic principles of clinical pharmacology relevant to pharmacoepidemiology studies', Pharmacoepidemiology, John Wiley & Sons, Hoboken 867 (2005) [B1]
2001O'Connell DL, Glasziou P, Hill SR, Sarunac J, Lowe J, Henry DA, 'Results of Clinical Trials and Systematic Reviews: To Whom Do They Apply?', The Advanced Handbook of Methods in Evidence Based Healthcare, Sage Publications Ltd, London England 56-72 (2001) [B1]
2001Hill SR, Henry DA, Stevens A, 'The use of evidence in drug selection: The Australian Pharmaceutical Benefits Scheme', Informing Judgment: Case Studies of Health Policy and Research in Six Countries, Milbank Memorial Fund, U.S.A. 7-27 (2001) [B2]
2000Hill SR, Henry DA, 'National Medicinal Drug Policies: their Relationship to Pharmacoepidemiology', Pharmacoepidemiology, John Wiley & Sons Ltd, Great Britain 433-447 (2000) [B1]
2000McGettigan PG, Henry DA, Hennessy S, 'Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies', Pharmacoepidemiology, John Wiley & Sons, West Sussex. England 41-62 (2000) [B1]
1999Henry DA, Drew A, Beuzeville S, 'Gastrointestinal Adverse Drug Reactions Attributed to Ibuprofen', Ibuprofen A critical bibliographic review, T.J. International Ltd., Cornwall UK 431-458 (1999) [B1]
Show 3 more

Journal article (115 outputs)

YearCitationAltmetricsLink
2014Robertson J, Doran E, Henry DA, Salkeld G, 'Prescription medicines: Decision-making preferences of patients who receive different levels of public subsidy', Health Expectations, 17 15-26 (2014)
2013Searles A, Doran E, Faunce TA, Henry D, 'The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?', AUSTRALIAN HEALTH REVIEW, 37 32-40 (2013) [C1]
2013Stukel TA, Glazier RH, Schultz SE, Guan J, Zagorski BM, Gozdyra P, Henry DA, 'Multispecialty physician networks in Ontario', Open Medicine, 7 1-16 (2013) [C1]
2013Robertson J, McElduff P, Pearson S-A, Henry DA, Inder KJ, Attia JR, 'The health services burden of heart failure: an analysis using linked population health data-sets (vol 12, pg 103, 2012)', BMC HEALTH SERVICES RESEARCH, 13 (2013)
2011McGettigan P, Lincz L, Attia JR, McElduff P, Bissett L, Peel R, et al., 'The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene', British Journal of Clinical Pharmacology, 72 707-714 (2011) [C1]
2011McGettigan P, Henry DA, 'Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies', PloS Medicine, 8 e1001098 (2011) [C1]
2010Lee DS, Stukel TA, Austin PC, Alter DA, Schull MJ, You JJ, et al., 'Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department', Circulation, 122 1806-1814 (2010) [C1]
2010Wilson AJ, Bonevski B, Jones AL, Henry DA, 'Deconstructing cancer: What makes a good-quality news story?', Medical Journal of Australia, 193 702-706 (2010) [C1]
2010Macneill PU, Kerridge IH, Newby DA, Stokes BJ, Doran E, Henry DA, 'Attitudes of physicians and public to pharmaceutical industry 'gifts'', Internal Medicine Journal, 40 335-341 (2010) [C1]
2010McEvoy MA, Smith WT, D'Este CA, Duke JM, Peel R, Schofield PW, et al., 'Cohort Profile: The Hunter Community Study', International Journal of Epidemiology, 39 1452-1463 (2010) [C1]
2010Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry DA, et al., 'The efficiency frontier approach to economic evaluation of health-care interventions', Health Economics, 19 1117-1127 (2010) [C1]
2010Wilson AJ, Robertson J, McElduff P, Jones AL, Henry DA, 'Does it matter who writes medical news stories?', PLoS Medicine, 7 1-5 (2010) [C1]
2010Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA, 'Cell salvage for minimising perioperative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, 1-181 (2010) [C1]
2010Robertson J, Walkom EJ, Moynihan R, Bero L, Henry DA, 'Pharmaceutical industry funding of educational events for pharmacists in Australia: An analysis of data from the first 6 months of a mandatory disclosure programme', International Journal of Pharmacy Practice, 18 88-92 (2010) [C1]
2010Carless PA, Henry DA, Carson JL, Hebert PPC, McClelland B, Ker K, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', Cochrane Database of Systematic Reviews, CD002042 (2010) [C1]
2010Henry DA, 'Doctors and drug companies: Still cozy after all these years', PLoS Medicine, 7 1-2 (2010) [C3]
2010Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry DA, et al., 'IQWiG methods - A response to two critiques', Health Economics, 19 1137-1138 (2010) [C3]
2009Henry DA, Carless PA, Fergusson D, Laupacis A, 'The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis', Canadian Medical Association Journal, 180 183-193 (2009) [C1]
2009Robertson J, Moynihan R, Walkom EJ, Bero L, Henry DA, 'Mandatory disclosure of pharmaceutical industry-funded events for health professionals', PLoS Medicine, 6 e1000128 (2009) [C1]
2008Doran E, Henry DA, Faunce TA, Searles AM, 'Australian pharmaceutical policy and the idea of innovation', Journal of Australian Political Economy, 62 39-61 (2008) [C1]
2008Doran E, Henry DA, 'Australian pharmaceutical policy: Price control, equity, and drug innovation in Australia', Journal of Public Health Policy, 29 106-120 (2008) [C1]
2008Doran E, Henry DA, 'Disease mongering: Expanding the boundaries of treatable disease', Internal Medicine Journal, 38 858-861 (2008) [C1]
2008McGettigan PG, Han PY, Jones LJ, Whitaker DE, Henry DA, 'Selective COX-2 inhibitors, NSAIDs and congestive heart failure: Differences between new and recurrent cases', British Journal of Clinical Pharmacology, 65 927-934 (2008) [C1]
2008Moynihan R, Doran E, Henry DA, 'Disease mongering is now part of the global health debate', PLoS Medicine, 5 0684-686 (2008) [C2]
2008Wodak AD, Ali R, Henry DA, Sansom L, 'Ensuring the safety of new medications and devices: Are naltrexone implants safe?', Medical Journal of Australia, 188 438-439 (2008) [C3]
2007Kelman CW, Pearson SA, Day RO, D'Arcy C, Holman J, Kliewer EV, Henry DA, 'Evaluating medicines: let's use all the evidence', Medical Journal of Australia, 186 249-252 (2007) [C1]
2007Searles AM, Jefferys S, Doran E, Henry DA, 'Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme', Medical Journal of Australia, 187 236-239 (2007) [C1]
2007Salkeld G, Henry DA, Hill SR, Lang DL, Freemantle N, D'Assuncao J, 'What drives health-care spending priorities? An international survey of health-care professionals', Plos Medicine, 4 256-259 (2007) [C1]
2007Pearson SA, Ringland C, Kelman C, Mant A, Lowinger J, Stark H, et al., 'Patterns of analgesic and anti-inflammatory medicine use by Australian veterans', Internal Medicine Journal, 37 798-805 (2007) [C1]
2007Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA, 'A Quality Use of Medicines program for general practitioners and older people: A cluster randomised controlled trial', Medical Journal of Australia, 187 23-30 (2007) [C1]

Co-authors: Julie Byles

2007Henry DA, Carless PA, Moxey AJ, O'Connell DL, Stokes BJ, McClelland B, et al., 'Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion', The Cochrane Database of Systematic Reviews, CD001886 (2007) [C1]
2007Henry DA, McGettigan PG, 'Cyclooxygenase inhibitors and cardiovascular risk - Reply', JAMA - Journal of the American Medical Association, 297 587-588 (2007) [C3]
2007Henry DA, McGettigan PG, 'Selective COX-2 inhibitors: A promise unfulfilled?', Gastroenterology, 132 790-794 (2007) [C3]
2006McGettigan PG, Henry DA, 'Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase', JAMA - Journal of the American Medical Association, 296 1633-1644 (2006) [C1]
2006McGettigan PG, Han PY, Henry DA, 'Cyclooxygenase-2 inhibitors and coronary occlusion - Exploring dose-response relationships', British Journal of Clinical Pharmacology, 62 358-365 (2006) [C1]
2006Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA, 'Cell Salvage for Minimising Perioperative Allogeneic Blood Transfusion', Cochrane Database of Systematic Reviews, 4 (2006) [C1]
2006Carless PA, Henry DA, 'Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery', British Journal of Surgery, 93 810-819 (2006) [C1]
2006McNeill PM, Kerridge IH, Henry DA, Stokes BJ, Hill SR, Newby DA, et al., 'Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia', Internal Medicine Journal, 36 571-578 (2006) [C1]
2006Doran E, Kerridge I, McNeill P, Henry DA, 'Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia', Social Science & Medicine, 62 1510-1519 (2006) [C1]
2006Moynihan R, Henry DA, 'The fight against disease mongering: Generating knowledge for action', Plos Medicine, 3 e191 (2006) [C2]
2006Doran E, Henry DA, 'Pharmaceutical benefits scheme policy: confused and tough on patients (Editorial)', Internal Medicine Journal, 36 211-213 (2006) [C3]
2006Harris A, Hill SR, Henry DA, 'Cost-effectiveness and resource allocation - Reply', JAMA - Journal of the American Medical Association, 295 2723-2724 (2006) [C3]
2006McNeill PM, Kerridge I, Henry DA, 'Reply', Internal Medicine Journal, 36 796-797 (2006) [C3]
2005Faunce T, Doran E, Henry DA, Drahos P, Searles A, Pekarsky B, Neville W, 'Assessing the impact of the Australian-United States free trade agreement on Australian and global medicines policy', Globalization and Health, 1 (2005) [C1]
2005Doran E, Robertson J, Henry DA, 'Moral hazard and prescription medicine use in Australia - the patient perspective', Social Science & Medicine, 60 1437-1443 (2005) [C1]
2005Henry DA, Hill SR, Harris A, 'Drug prices and value for money: The Australian Pharmaceutical Benefits Scheme (Commentary)', Journal of the American Medical Association, 294 2630-2632 (2005) [C1]
2005Smith DE, Wilson AJ, Henry DA, 'Monitoring the quality of medical news reporting: Early experience with media doctor', Medical Journal of Australia, 183 190-193 (2005) [C1]

Co-authors: Amanda Wilson

2005Carless PA, Moxey AJ, Stokes BJ, Henry DA, 'Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials', BMC Cardiovascular Disorders, 5 (2005) [C1]
2005Day RO, Birkett DJ, Miners J, Shenfield GM, Henry DA, Seale JP, 'Access to medicines and high-quality therapeutics: Global responsibilities for clinical pharmacology (Conference report)', Medical Journal of Australia, 182 322-323 (2005) [C1]
2005McGettigan PG, Henry DA, 'Medical research and the news media', New England Journal of Medicine, 352 838-840 (2005) [C1]
2005Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, et al., 'Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience', Medical Journal of Australia, 182 557-560 (2005) [C1]
2005Moxey AJ, O'Connell DL, Treloar CJ, Han PYS, Henry DA, 'Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public', Transfusion Medicine, 15 19-32 (2005) [C1]
2005Schwitzer G, Mudur G, Henry DA, Wilson AJ, Goozner M, Simbra M, et al., 'What are the roles and responsibilities of the media in disseminating health information?', Plos Medicine, 2 576-582 (2005) [C1]
2005Henry DA, Doran E, Kerridge I, Hill SR, McNeill PM, Day R, 'Ties that bind - Multiple relationships between clinical researchers and the pharmaceutical industry', Archives of Internal Medicine, 165 2493-2496 (2005) [C1]
2005Kerridge I, Maguire JM, Newby DA, McNeill PM, Henry DA, Hill SR, et al., 'Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations', Internal Medicine Journal, 35 206-210 (2005) [C1]
2005Carless PA, Henry DA, 'Systematic review of autologous transfusion techniques (Reply)', Transfusion Medicine, 15 256-256 (2005) [C3]
2004Carless PA, Moxey AJ, O'Connell DL, Henry DA, 'Autologous transfusion techniques: systematic review of their efficacy', Transfusion Medicine, 14 123-144 (2004) [C1]
2004Drahos P, Lokuge B, Faunce T, Goddard M, Henry DA, 'Pharmaceuticals, Intellectual Property and Free Trade: The Case of the US-Australia Free Trade Agreement', Prometheus, 22 243-257 (2004) [C1]
2004Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al., 'Grading quality of evidence and strength of recommendations', BMJ, 328 1-8 (2004) [C1]
2004Doran E, Robertson J, Rolfe IE, Henry DA, 'Patient co-payments and use of prescription medicines', Australian and New Zealand Journal of Public Health, 28 62-67 (2004) [C1]
2004Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry DA, Hill SR, et al., 'Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group', BMC Health Services Research, 4 1-7 (2004) [C1]
2004Mansfield P, Henry DA, Tonkin A, 'Single-Enantiomer Drugs. Elegant Science, Disappointing Effects', Clinical Pharmacokinetics, 43 287-290 (2004) [C1]
2004Mansfield PR, Henry DA, 'Misleading drug promotion- no sign of improvements', Pharmacoepidemiology and drug safety, 13 797-799 (2004) [C3]
2004Drahos P, Henry DA, 'The free trade agreement between Australia and the United States, Undermines Australian public health and protects US interests in pharmaceuticals', BMJ, 328 1271-1272 (2004) [C3]
2003Carless PA, Rubens FD, Anthony DM, O'Connell DL, Henry DA, 'Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, - CD004172 (2003) [C1]
2003Doran E, Henry DA, 'The PBS community awareness campaign: how helpful is blaming patients', Medical Journal of Australia, 179 544-545 (2003) [C1]
2003Lelorier J, Vander Stichele RH, Avorn J, Beard K, Hallas J, Henry DA, 'Bringing epidemology into drug utilisation research', Pharmacoepidemiology & Drug Safety: an International Journal, 12 153-156 (2003) [C1]
2003Robertson J, Treloar CJ, Sprogis A, Henry DA, 'The influence of specialists on prescribing GPs: A qualitative study', Australian Family Physician, 32 (2003) [C1]
2003Newby DA, Fryer JL, Henry DA, 'Effect of computerised prescribing on use of antibiotics', Medical Journal of Australia, 178 210-213 (2003) [C1]

Co-authors: David Newby

2003Moxey AJ, O'Connell DL, McGettigan PG, Henry DA, 'Describing treatment effects to patients: How they are expressed makes a difference', Journal of General Internal Medicine, 18 948-959 (2003) [C1]
2003Henry DA, McGettigan PG, 'Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs', International Journal of Clinical Practice, 135 43-49 (2003) [C1]
2003Henry DA, Lexchin J, 'Patent law', The Lancet, 361 1059 (2003) [C3]
2003Henry DA, Lang DL, 'Published pharmacoeconomic analyses: science or marketing?', Internal Medicine Journal, 33 404-404 (2003) [C3]
2003Henry DA, Lexchin J, 'Pfizer Diflucan Partnership Program: Authors' reply', The Lancet, 361 72 (2003) [C3]
2003Carless PA, Henry DA, Anthony DM, 'Fibrin sealant use for minimising peri-operative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, 4 (2003) [C3]
2003Henry DA, Salkeld G, 'Bridges to Iran', The Lancet, 361 438 (2003) [C3]
2002Lopert R, Lang DL, Hill SR, Henry DA, 'Differential pricing of drugs: a role for cost-effectiveness analysis?', The Lancet, 359 2105-2107 (2002) [C1]
2002Moynihan R, Heath I, Henry DA, 'Selling sickness: The pharmaceutical industry and disease mongering', British Medical Journal, 324 886-891 (2002) [C1]
2002Henry DA, Lexchin J, 'The Pharmaceutical Industry as a medicines provider', The Lancet, 360 1590-1595 (2002) [C1]
2002Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, et al., 'V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women', Endocrine Reviews, 23(4) 529-539 (2002) [C1]
2002Robertson J, Fryer JL, O'Connell DL, Smith AN, Henry DA, 'Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators', Medical Journal of Australia, 176 419-424 (2002) [C1]
2002Lopert R, Henry DA, 'The Pharmaceutical Benefits Scheme: economic evaluation works ... but is not a panacea', Australian Prescriber, 25(6) 126-127 (2002) [C1]
2002Carson J, Hill SR, Carless PA, Hebert P, Henry DA, 'Transfusion Triggers: a systematic review of the literature', Transfusion Medicine Reviews, 16(3) 187-199 (2002) [C1]
2002Carless PA, Anthony DM, Henry DA, 'Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion', British Journal of Surgery, 89 695-703 (2002) [C1]
2002Henry DA, Carless PA, Moxey A, O'Connell DL, Forgie M, Wells P, Fergusson D, 'Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion', The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
2002Newby DA, Henry DA, 'Drug advertising: truths, half-truths and few statistics', Medical Journal of Australia, 177(6) 285-286 (2002) [C3]

Co-authors: David Newby

2002Hill SR, Carless PA, Henry DA, Carson J, Hebert P, McClelland D, Henderson K, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
2001Newby DA, Hill SR, Barker B, Drew A, Henry DA, 'Drug information for consumers: should it be disease or medication specific? Results of a community survey', Australian and New Zealand Journal of Public Health, 25(6) 564-570 (2001) [C1]

Co-authors: David Newby

2001Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA, 'The impact of specialists on prescribing by general practitioners', Medical Journal of Australia, 175 407-411 (2001) [C1]
2001Robertson J, Fryer JL, O'Connell DL, Smith AN, Henry DA, 'Personal Formularies. An index of prescribing quality?', European Journal of Clinical Pharmacology, 57 333-341 (2001) [C1]
2001Treloar C, Hewitson P, Henderson KM, Harris G, Henry DA, McGrath K, 'Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: an interview study of national and institutional stakeholders', Internal Medicine Journal, 31 230-236 (2001) [C1]
2001Henry DA, Birkett D, 'Changes to the Pharmaceutical Benefits Advisory Committee', Medical Journal of Australia, 174(5) 209-210 (2001) [C3]
2000Henry DA, Henderson KM, Fryer JL, Treloar C, McGrath K, Deveridge S, 'Use of interventions to minimise perioperative allogeneic blood transfusion in Australia', Medical Journal of Australia, 172 365-369 (2000) [C1]
2000Page J, Henry DA, 'Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients', Archives of Internal Medicine, 160(6) 777-784 (2000) [C1]
2000Lowe J, Candish P, Henry DA, Wlodarcyk J, Fletcher P, 'Specialist or generalist care? A study of the impact of a selective admitting policy for patients with cardiac failure', International Journal for Quality in Health Care, 12(4) 339-345 (2000) [C1]
2000Moynihan M, Bero B, Ross-Degnan R, Henry DA, Lee L, Soumerai H, 'Coverage by the news media of the benefits and risks of medications', The New England Journal of Medicine, 342(22) 1645-1650 (2000) [C1]
2000Hill SR, Mitchell A, Henry DA, 'Problems with the Interpretation of Pharmacoeconomic Analyses', JAMA, 283(16) 2116-2121 (2000) [C1]
2000McManus M, Henry DA, Birkett B, 'Recent changes in the profile of prescription NSAID use in Australia', Medical Journal of Australia, 172 188 (2000) [C3]
2000Henry DA, McGettigan PG, 'Rofecoxib caused few endoscopic gastroduodenal ulcers than ibuprofen in osteoarthritis ( Laine L et al/Celecoxib was similar to naproxen for rheumatoid arthritis with fewer endoscopic ulcers (Simon LS et al) - Commentary', Evidence-Based Medicine (EBM), 5 74 (2000) [C3]
1999Henry DA, Lopert R, 'Pharmacoeconomics and Policy Decisions: The Australian Health Care System', Clinical Therapeutics, 21(5) 909-915 (1999) [C1]
1999O'Connell DL, Henry DA, Tomlins R, 'Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia', British Medical Journal, 318 507-511 (1999) [C1]
1999Whitworth J, Lang DL, Henry DA, 'Cost-effectiveness Analysis in the Treatment of Hypertension: A Medical View', Clinical and Experimental Hypertension, 21(5-6) 999-1008 (1999) [C1]
1999Robertson J, Henry DA, Dobbins T, Sprogis A, Terry R, Ireland M, 'Prescribing patterns in general practice', Australian Family Physician, 28 (11) 1186-1190 (1999) [C1]
1999McGettigan PG, Sly K, O'Connell DL, Hill SR, Henry DA, 'The Effects of Information Framing on the Practices of Physicians', Journal of General Internal Medicine, 14 633-642 (1999) [C1]
1999Ferguson D, Blair A, Henry DA, Hisashige A, Huet C, Koopman-Van Gemert A, et al., 'Technologies to minimize blood transfusion in cardiac and orthopedic surgery', International Journal of Technology Assessment in Health Care, 15 (4) 717-728 (1999) [C1]
1999Henry DA, Hill SR, 'Assessing new health technologies: lessons to be learned from drugs', Medical Journal of Australia, 171 554-556 (1999) [C1]
1999Nikolajevic-Sarunac J, Henry DA, O'Connell DL, Robertson J, 'Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy', Journal of General Internal Medicine, 14 591-598 (1999) [C1]
1999Henry DA, Robertson J, 'Pharmacists' outreach visits and doctors' prescribing', Medical Journal of Australia, 170 460-461 (1999) [C2]
1999Henry DA, Hill SR, 'Meta-analysis - Its Role in Assessing Drug Safety', Pharmacoepidemiology and Drug Safety, 8(3) 167-168 (1999) [C2]
1998Henry DA, Robertson J, O'Connell DL, Gillespie W, 'A systematic review of the skeletal effects of estrogen therapy in post-menopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995', Climacteric, 1 (2) 92-111 (1998) [C1]
1998Kerridge I, Lowe M, Henry DA, 'Ethics and Evidence-Based Medicine', British Medical Journal, 316 1151-1153 (1998) [C1]
1998O'Connell DL, Robertson J, Henry DA, Gillespie W, 'A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects', Climacteric, 1 (2) 112-123 (1998) [C1]
1998Lowe J, Candish P, Henry DA, Wiodarcul J, Heller E, Fletcher P, 'Management and outcomes of congestive heart failure: a prospective study of hospitalised patients', Medical Journal of Australia, 168 115-118 (1998) [C1]
1998Porteous J, Robertson J, Henry DA, 'Pharmaceutical security: a new research agenda?', The Medical Journal of Australia, 169 (5) 262-263 (1998) [C2]
1998Henry DA, 'Commentary', ACP Journal Club, July/August 1998 10 (1998) [C3]
Show 112 more

Review (3 outputs)

YearCitationAltmetricsLink
2004Hill SR, Carless PA, Henry DA, Carlson JL, Herbert PC, McClelland DBL, Henderson KM, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', Cochrane Database of Systematic Reviews (2004) [D1]
2003Aaserud M, Dahlgren AT, Sturm H, Kosters JP, Hill SR, Furberg CD, et al., 'Pharmaceutical policies: effects on rational drug use', Cochrane Database of Systematic Reviews (2003) [D1]
2003Henry DA, Moxey AJ, Carless PA, O'Connell DL, McClelland B, Henderson KM, et al., 'Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion', Cochrane Database of Systematic Reviews (2003) [D2]

Conference (4 outputs)

YearCitationAltmetricsLink
2004Moxey AJ, O'Connell DL, Deveridge SF, Treloar CJ, Henry DA, 'Involving older patients in decision making: a decision aid describing blood transfusion options for planned surgery', Abstracts and Proceedings of ERA 2004, Brisbane (2004) [E1]
2001Carless PA, Hill SR, Henry DA, 'How low can we go? Lower thresholds for red cell transfusion', Destination downunder turning your thinking upside down : proceedings of the 4th International Conference on the Scientific Basis of Health Services, Sydney, Australia (2001) [E3]
1998Henry DA, Drew A, Beuzeville S, 'Adverse drug reactions in the gastrointestinal system attributed to ibuprofen', Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs, South San Francisco Conference Centre (1998) [E1]
1998McGettigan PG, Henry DA, Page J, 'Adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal tract and kidney: Relationship to cyclooxygenase-2 selectivity', Clinical significance and potential of selective COX-2 inhibitors, Phuket, Thailand (1998) [E2]
Show 1 more
Edit

Grants and Funding

Summary

Number of grants52
Total funding$12,678,379

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2008 (1 grants)

Pharmaceutical Promotion: Productive or Problematic?$150,000
Funding Body: ARC (Australian Research Council)

Project Team
Doctor Evan Doran, Conjoint Professor David Henry, Mr Ray Moynihan
SchemeRole
Discovery ProjectsInvestigator
Total AmountFunding StartFunding Finish
$150,00020082009
GNo:G0187476

2007 (5 grants)

NIPH Capacity Building Infrastructure grant$1,472,398
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor David Henry, Professor Julie Byles, Professor John Wiggers, Conjoint Associate Professor Julia Lowe, Conjoint Professor David Durrheim
SchemeRole
NIPH Capacity Building Infrastructure grantChief Investigator
Total AmountFunding StartFunding Finish
$1,472,39820072009
GNo:G0187399

Moral Hazard and the Pharmaceutical Benefits Scheme$166,000
Funding Body: ARC (Australian Research Council)

Project Team
Doctor Evan Doran, Conjoint Professor David Henry, Associate Professor G Salkeld, Doctor Jane Robertson
SchemeRole
Discovery ProjectsInvestigator
Total AmountFunding StartFunding Finish
$166,00020072008
GNo:G0186334

Improving the quality of health news reports in the Australian media$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor David Henry, Doctor Amanda Wilson
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0187253

The quality of health news reports about complementary and alternative medicine in Australian lay media$8,702
Funding Body: University of Newcastle

Project Team
Conjoint Professor Alison Jones, Associate Professor Billie Bonevski, Conjoint Professor David Henry, Doctor Amanda Wilson
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$8,70220072007
GNo:G0187836

Sri Lanka Medical Association 120th Annual Scientific Sessions, Colombo, 21/3/2007 - 24/3/2007$1,462
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,46220072007
GNo:G0187382

2006 (5 grants)

PRC - Priority Research Centre for Gender health & Ageing$543,772
Funding Body: University of Newcastle

Project Team
Professor Julie Byles, Professor Sandra Capra, Associate Professor Pauline Chiarelli, Conjoint Professor David Henry, Professor Tina Koch, Ms Chris Landorf, Conjoint Professor Chris Levi, Associate Professor Deb Loxton, Associate Professor Liz Milward, Conjoint Associate Professor Lynne Parkinson, Professor Dimity Pond, Conjoint Professor David Sibbritt, Associate Professor Anne Young
SchemeRole
Priority Research CentreInvestigator
Total AmountFunding StartFunding Finish
$543,77220062013
GNo:G0186949

Harmful or protective: low-dose selective cox-2 inhibitors and coronary or cerebrovascular occlusion$111,000
Funding Body: National Heart Foundation of Australia

Project Team
Conjoint Professor David Henry, Dr Patricia McGettigan
SchemeRole
Grant-In-AidChief Investigator
Total AmountFunding StartFunding Finish
$111,00020062007
GNo:G0185371

Harmful or protective? Low dose COX-2 inhibitors and coronary or cerebrovascular occlusion$20,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry, Dr Patricia McGettigan, Conjoint Professor Chris Levi
SchemeRole
Near Miss GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020062006
GNo:G0186057

Establishing a linked record system to optimise the use of longitudinal health-related datasets: illustrated by two studies of medication use$19,688
Funding Body: University of Newcastle

Project Team
Associate Professor Anne Young, Conjoint Associate Professor Lynne Parkinson, Professor Julie Byles, Conjoint Professor David Henry
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$19,68820062007
GNo:G0186687

XIV Cochrane Colloquium, Dublin 2006, 23-27 October 2006$2,400
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,40020062006
GNo:G0186970

2005 (3 grants)

External Evaluation of PBAC Submissions RFP 163/0304$3,221,378
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Doctor Jane Robertson, Conjoint Professor David Henry
SchemeRole
Consultancy/TenderInvestigator
Total AmountFunding StartFunding Finish
$3,221,37820052008
GNo:G0184477

The impact of International Trade Agreements on the regulation and provision of medicines in Australia$116,088
Funding Body: ARC (Australian Research Council)

Project Team
Conjoint Professor David Henry
SchemeRole
Discovery ProjectsChief Investigator
Total AmountFunding StartFunding Finish
$116,08820052008
GNo:G0185098

Establishment of a Clinical Research Database for Hunter Stroke Service$20,000
Funding Body: Hunter New England Area Health Service

Project Team
Conjoint Professor David Henry
SchemeRole
Hunter Stroke ServiceChief Investigator
Total AmountFunding StartFunding Finish
$20,00020052005
GNo:G0185608

2004 (2 grants)

Novel genetic and environmental risk factors in atherothrombosis: The role of variation in Cox-2, tpA and PAI-1 activity$28,000
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Chris Levi, Conjoint Professor David Henry, Dr Patricia McGettigan, Professor John Attia, Professor Mark Parsons, Dr Michael Seldon, Professor Rodney Scott
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$28,00020042004
GNo:G0183749

The Cochrane Collaboration Colloquium, 2-6 October 2004, Canada$1,586
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,58620042004
GNo:G0184822

2003 (1 grants)

COX-2 inhibitors and the development of unstable angina and myocardial infarction$161,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry, Dr Patricia McGettigan, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$161,00020032005
GNo:G0181781

2002 (1 grants)

COX-2 inhibitors as a cause of heart and renal failure$271,500
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry, Dr Patricia McGettigan, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe, Conjoint Professor Ian Whyte
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$271,50020022004
GNo:G0180892

2001 (3 grants)

An investigation of the relationship between the pharmaceutical industry, medical profession and medical practitioners.$185,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Dr Ian Kerridge, Conjoint Professor David Henry, Associate Professor Suzanne Hill, Assoc. Prof P McNeill
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$185,00020012002
GNo:G0179679

Cochrane Colloquium (annual meeting) France 9-13 October, 2001$2,143
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,14320012001
GNo:G0181555

To Provide Independent Reviews of Draft Health Advisory Reports.$1
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Associate Professor Rosemary Aldrich, Conjoint Associate Professor Julia Lowe, Conjoint Professor David Henry, Professor Julie Byles
SchemeRole
Consultancy/TenderInvestigator
Total AmountFunding StartFunding Finish
$120012001
GNo:G0180846

2000 (2 grants)

Alternatives to homologous blood transfusion - development of evidence-based decision aids.$213,697
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Doctor Sandra Deveridge
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$213,69720002001
GNo:G0178462

Review of the risks associated with the use of NSAID's.$82,453
Funding Body: Whitehall-Robbins Health Care Division

Project Team
Conjoint Professor David Henry
SchemeRole
American Home Products CorporationChief Investigator
Total AmountFunding StartFunding Finish
$82,45320002001
GNo:G0180168

1999 (1 grants)

Pharmaceutical Affordability and the Quality Use of Medicines.$75,000
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Doctor Evan Doran, Conjoint Professor David Henry
SchemeRole
Pharmaceutical Education Program (PEP)Investigator
Total AmountFunding StartFunding Finish
$75,00019992001
GNo:G0178749

1998 (8 grants)

External Evaluation of PBAC Submissions$3,761,049
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Associate Professor Suzanne Hill, Conjoint Professor David Henry
SchemeRole
Consultancy/TenderInvestigator
Total AmountFunding StartFunding Finish
$3,761,04919982004
GNo:G0178712

Integrated Care Program.$150,000
Funding Body: Merck Sharp & Dohme Aust Pty Ltd

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$150,00019982000
GNo:G0178621

The effect of different forms of information framing on helath care practices$122,786
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$122,78619981999
GNo:G0177173

Developing Assessment Guidelines for the Medicare Services Advisory Committee$121,885
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry
SchemeRole
Medicare Services Advisory CommitteeChief Investigator
Total AmountFunding StartFunding Finish
$121,88519981998
GNo:G0178236

Development of a strategy to measure consumer participation in decisions about health service delivery$56,063
Funding Body: NSW Ministry of Health

Project Team
Professor Jill Cockburn, Conjoint Professor David Henry, Associate Professor David Newby
SchemeRole
Ministerial Advisory Committee - Quality in Health CareInvestigator
Total AmountFunding StartFunding Finish
$56,06319981999
GNo:G0177842

Improving treatment decisions: accurate generalisation of clinical trial results$49,626
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$49,62619981999
GNo:G0177174

A Review of the Scientific Literature Concerning the Alternatives to Homologous Blood Donations$39,121
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry
SchemeRole
Health Goals & TargetsChief Investigator
Total AmountFunding StartFunding Finish
$39,12119981998
GNo:G0177846

Attendance and participation in the International Society of Technology Assessement in Health Care conference (ISTAHC) - Ottowa$3,330
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry
SchemeRole
Medicare Services Advisory CommitteeChief Investigator
Total AmountFunding StartFunding Finish
$3,33019981998
GNo:G0177970

1997 (7 grants)

Review of the Consumer Drug Information Services$106,518
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Associate Professor David Newby, Conjoint Professor David Henry, Associate Professor Suzanne Hill
SchemeRole
Pharmaceutical Education Program (PEP)Investigator
Total AmountFunding StartFunding Finish
$106,51819971997
GNo:G0177050

Newcastle Prescriber Database$78,250
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Doctor Jane Robertson
SchemeRole
General Practice Evaluation Program (GPEP) (Defunct)Chief Investigator
Total AmountFunding StartFunding Finish
$78,25019971999
GNo:G0176055

The impact of specialists on prescribing by Australian general practitioners.$77,357
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry, Doctor Arn Sprogis, Doctor Jane Robertson
SchemeRole
General Practice Evaluation Program (GPEP) (Defunct)Chief Investigator
Total AmountFunding StartFunding Finish
$77,35719971997
GNo:G0177040

Value of non-randomised studies for assessing the effectiveness of medical interventions$67,698
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$67,69819971998
GNo:G0176234

Public Participation in Resource Allocation in Health$43,600
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Associate Professor David Newby, Conjoint Professor David Henry, Doctor Gloria Higginbottom, Professor Jill Cockburn, Associate Professor Suzanne Hill
SchemeRole
Pharmaceutical Education Program (PEP)Investigator
Total AmountFunding StartFunding Finish
$43,60019971997
GNo:G0177552

Evaluation of Hospital in the Home - design of protocol$4,906
Funding Body: Macquarie Health Corporation

Project Team
Conjoint Professor David Henry
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$4,90619971997
GNo:G0177004

International Congress in Pharmacoepidemiology, Orlando, Florida, 24-27 August 1997$2,500
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,50019971997
GNo:G0179481

1996 (3 grants)

Development, Testing and Refining of Indicators of Quality of Prescribing by General Practitioners$66,108
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Jane Robertson, Conjoint Professor David Henry
SchemeRole
PHRDC Research Fellowship (Defunct)Investigator
Total AmountFunding StartFunding Finish
$66,10819961999
GNo:G0177702

Phamaceuticals Project Stage 2$20,000
Funding Body: Consumers` Health Forum of Australia Inc.

Project Team
Conjoint Professor David Henry, Ms B Pekarsky
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00019961996
GNo:G0176517

An examination of the risk of sudden death during therapeutic use of thioridazine and desipramine by systematic review of randomised controlled trials$11,500
Funding Body: University of Newcastle

Project Team
Dr Nicholas Buckley, Conjoint Professor David Henry
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$11,50019961996
GNo:G0175828

1995 (4 grants)

The External Evaluation of PBAC Submissions$555,741
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry
SchemeRole
Pharmaceutical Education Program (PEP)Chief Investigator
Total AmountFunding StartFunding Finish
$555,74119951997
GNo:G0175545

Assessing and increasing the generalisabiity of RCTs$107,448
Funding Body: UK National Health Service

Project Team
Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Professor D Sackett, Mr P Glasziou
SchemeRole
Research & Development Program GrantsChief Investigator
Total AmountFunding StartFunding Finish
$107,44819951995
GNo:G0175419

Conducting Analysis on Prescribing for Major Groups of Prescription Pharmacueticals which might explain the Variability in Prescribing Rates and Total ...$48,632
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry
SchemeRole
Research & Development Grant (RADGAC)Chief Investigator
Total AmountFunding StartFunding Finish
$48,63219951995
GNo:G0175210

General Practitioners Beliefs Regarding Benefits and Risks of Hormone Replacement Therapy$22,246
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Conjoint Professor David Henry
SchemeRole
Research & Development Grant (RADGAC)Chief Investigator
Total AmountFunding StartFunding Finish
$22,24619951995
GNo:G0175208

1994 (2 grants)

94GRANT. Speciality grant for Pharmacoepidemiology.$120,000
Funding Body: Commonwealth Department of Health & Aged Care

Project Team
Emeritus Professor Anthony Smith, Conjoint Professor David Henry
SchemeRole
Pharmaceutical Education Program (PEP)Investigator
Total AmountFunding StartFunding Finish
$120,00019941994
GNo:G0174635

10 International Conference on Pharmacoepidemiology - Stockholm - 28-31 August 1994$2,500
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,50019941994
GNo:G0175071

1993 (2 grants)

A Meta-Analysis of Falls in Old Age.$10,000
Funding Body: University of Newcastle

Project Team
Paul Finucane, Conjoint Professor David Henry
SchemeRole
New Staff GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00019931993
GNo:G0172985

'9th International Conference on Pharmacoepidemiology', JW Marriott Hotel, Washington DC, USA, 29 August - 1 September 1993$560
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$56019931993
GNo:G0174397

1992 (2 grants)

Acute Renal Impairment And Cardiac Failure With Nsaids. A Community Study.$133,341
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor David Henry
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$133,34119921993
GNo:G0174270

12th International Meeting of the International Society of Technology Assessment in Health Care, San Francisco, 23-26 June 1996$2,346
Funding Body: University of Newcastle

Project Team
Conjoint Professor David Henry
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,34619921992
GNo:G0176432
Edit

Research Supervision

Number of current supervisions0

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Past Supervision

YearProgramSupervisor TypeResearch Title
2010PhD (CommunityMed & ClinEpid)Co-SupervisorAssessing the Quality of Health News Stories in the Australian Media Using the Media Doctor Website
2010PhD (CommunityMed & ClinEpid)Principal SupervisorA Preliminary Analysis of the Pharmaceutical Provisions in the Australia-United States Free Trade Agreement on Prescription Medicines in Australia
2007PhD (Clinical Pharm)Principal SupervisorEvidence-Based Patient Decision Making: The Development of a Decision Aid on Blood Transfusion
2005PhD (Clinical Pharm)Co-SupervisorEvaluation of Aspects of the South African National Drug Policy: Hypertension, a Case Study
2003PhD (Clinical Pharm)Principal SupervisorPharmaceutical Affordability and Quality Use of Medicines
2002PhD (Clinical Pharm)Principal SupervisorPublic Participation in Health Care Decisions about Medicines
Edit

Conjoint Professor David Henry

Work Phone+14163716947 (Canada)
Fax(02) 4960 2088
Email
PositionConjoint Professor
School of Medicine and Public Health
Faculty of Health and Medicine
The University of Newcastle, Australia
URL:www.newcastle.edu.au/profile/david-henry